Closeup of David Moore

David J. Moore, Ph.D.

Pronouns: he, him

Co-Director, SDSU / UC San Diego JDP in Clinical Psychology
Professor of Psychiatry

UC San Diego Health
Department of Psychiatry

Office Hours

By Appointment

Location
UC San Diego
9500 Gilman Drive
La Jolla, CA 92093
Mail Code
[1234]
Fax
[619-594-####]

Areas of Expertise

HIV Infections, AIDS Dementia Complex, Neurocognitive Disorders, Medication Adherence, Frailty

Student Opportunities

  1. [Opportunity 1]
  2. [Opportunity 2]

Bio

Dr. Moore received his doctorate from the SDSU/UCSD Joint Doctoral Program in Clinical Psychology with a specialization in neuropsychology. After completing his clinical internship at the West Los Angeles VA, he returned to UCSD for a post-doctoral fellowship focusing on individuals with serious mental illness. Currently, he is a licensed clinical psychologist and an Associate Professor conducting research at the HIV Neurobehavioral Research Program (HNRP). He focuses on neurocognitive impairment and daily functioning difficulty among persons with co-occurring HIV infection, serious mental illness, and substance use disorders. He has a particularly interest in technological interventions to improve medication adherence. Dr. Moore is also a faculty member of the SDSU/UCSD Joint Doctoral Program in Clinical Psychology.

Dr. Moore’s research focuses on the neuropsychological and everyday functioning difficulties of individuals with HIV infection He is a Principal Investigator on several ongoing HIV-related research studies that are supported by NIMH, NIDA, and the California HIV/AIDS Research Program (CHRP). One of his primary research foci is examining the neurocognitive complications associated with HIV infection and other comorbid disorders (e.g., psychiatric and substance use disorders) and how neurocognitive difficulties relate to everyday functioning. In addition, Dr. Moore has a keen interest in the intersection of HIV and aging, and in identifying factors associated with successfully aging with HIV infection. Much of his recent work has focused on developing innovative, personalized, scalable text messaging interventions to improve antiretroviral medication adherence.

Details

Courses
  1. [COURSE 1 – Title]
  2. [COURSE 2 – Title]
  3. [COURSE 3 – Title]
Education
  1. Ph.D.
    SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego
Publications
  1. Identifying Syndemic Factors and Their Effect on HIV Sexual Risk Behavior Among Gay, Bisexual and Other Men Who Have Sex with Men in Vancouver, Montreal and Toronto. AIDS Behav. 2025 May 23. Duailibe F, Shen T, Zhang W, Moore D, Hull M, Barath J, Magee C, Lachowsky N, Hart T, Cox J, Grace D, Lambert G, Skakoon-Sparling S, Jollimore J, Dvorakova M, Gormezano A, Lima VD. PMID: 40405027.
  2. The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV. Clin Infect Dis. 2025 Apr 30; 80(4):871-880. Kamkwalala AR, Matthews A, Garg A, Roy U, Ma Q, Karris M, Sundermann E, Ellis RJ, Riggs PK, Trunfio M, Blanchard J, Moore DJ, Rubin LH, Letendre SL. PMID: 39658021; PMCID: PMC12043063.
  3. Independent and combined adverse effects of neurocognitive impairment and depression on everyday functioning and quality of life in people with HIV. J Int Neuropsychol Soc. 2025 Apr 29; 1-10. Wang CX, Chentsova VO, Prescott MR, Umlauf A, Moore DJ, Ellis RJ, Cherner M, Stein MB, Letendre SL, Heaton RK, Iudicello JE. PMID: 40296476.
  4. Minority stress and stimulant use among US adult sexual minority men: A systematic review. Drug Alcohol Depend Rep. 2025 Jun; 15:100333. Miller-Perusse M, Horvath KJ, Montoya JL, Moore DJ, Carrico AW, Serrano VB. PMID: 40342403; PMCID: PMC12059404.
  5. Positive Psychological Factors Relate to Domain-Specific Cognition and Daily Functioning in Middle-Aged and Older Adults with HIV. AIDS Behav. 2025 May; 29(5):1669-1680. Ham L, Kohli M, Tang B, Grant I, Moore DJ. PMID: 40029576; PMCID: PMC12031858.
  6. Impacts of overdose and socio-structural factors on recent mortality among people with HIV in British Columbia, Canada. AIDS. 2025 Jul 01; 39(8):1055-1064. Tam C, Zhang W, Moore D, Salters K, Trigg J, Wesseling T, Parashar S, McLinden T, Sereda P, McDougall P, Moher M, Montaner JSG, Hogg R, Barrios R. PMID: 39992124.
  7. Predicting Trajectories of Everyday Functioning in Adults Aging with HIV Using Latent Growth Mixture Modeling. AIDS Behav. 2025 May; 29(5):1525-1539. Ham L, Roesch S, Franklin DR, Ellis RJ, Grant I, Moore DJ. PMID: 39928071; PMCID: PMC12031941.
  8. Relationships between neurodivergence status and adverse childhood experiences, and impacts on health, wellbeing, and criminal justice outcomes: findings from a regional household survey study in England. BMC Med. 2024 Dec 18; 22(1):592. Wilson C, Butler N, Quigg Z, Moore D, Bellis M. PMID: 39695633; PMCID: PMC11657135.
  9. Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings From the 14th Annual International Workshop on HIV and Aging. J Gerontol A Biol Sci Med Sci. 2024 Dec 11; 80(1). Baim-Lance A, Cooley S, Yoo-Jeong M, Ances B, Duque G, Ellis RJ, Flexner C, Pence BW, Plankey M, Mullins JD, Sun J, Thames AD, Margolick JB, Moore DJ, Erlandson KM. PMID: 39492669.
  10. Fostering healthy cognitive ageing in people living with HIV. Lancet HIV. 2025 Jan; 12(1):e71-e80. Cysique LA, Levin J, Howard C, Taylor J, Rule J, Costello J, Bruning J, Njeri P, Mullens AB, Wright E, Gouse H, Daken K, Trunfio M, Aung HL, Robbins RN, Ferraris CM, Muñoz-Moreno JA, Woods SP, Moore DJ, Power C, Wong PL, Hasmukharay K, Nyamayaro P, Vera J, Rajasuriar R, Heaton RK, Goodkin K, Letendre S, Ellis RJ, Brew BJ, Rourke SB, NeuroHIV and Aging Advocacy Group. PMID: 39615509.
  11. The prefrontal cortex, but not the medial temporal lobe, is associated with episodic memory in middle-aged persons with HIV. J Int Neuropsychol Soc. 2024 Dec; 30(10):966-976. Campbell LM, Fennema-Notestine C, Sundermann EE, Barrett A, Bondi MW, Ellis RJ, Franklin D, Gelman B, Gilbert PE, Grant I, Heaton RK, Moore DJ, Morgello S, Letendre S, Patel PB, Roesch S, Moore RC. PMID: 39545285; PMCID: PMC11735296.
  12. Prevalence of Oral Human Papillomavirus Infection Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men in Canada, 2017-2019. J Infect Dis. 2024 Nov 15; 230(5):e1039-e1048. Alessandrini J, Cox J, de Pokomandy A, Hart TA, Grace D, Grennan T, Moore D, Lambert G, Chambers C, Deeks SL, Grewal R, Lachowsky NJ, Sauvageau C, Tan DHS, Coutlée F, Burchell AN, Engage-HPV Team . PMID: 39041706; PMCID: PMC11566233.
  13. The microbiome diversifies N-acyl lipid pools – including short-chain fatty acid-derived compounds. bioRxiv. 2024 Nov 02. Mannochio-Russo H, Charron-Lamoureux V, van Faassen M, Lamichhane S, Nunes WDG, Deleray V, Patan A, Vittali K, Rajkumar P, El Abiead Y, Zhao HN, Gomes PWP, Mohanty I, Lee C, Sund A, Sharma M, Liu Y, Pattynama D, Walker GT, Norton GJ, Khatib L, Andalibi MS, Wang CX, Ellis RJ, Moore DJ, Iudicello JE, Franklin D, Letendre S, Chin L, Walker C, Renwick S, Zemlin J, Meehan MJ, Song X, Kasper D, Burcham Z, Kim JJ, Kadakia S, Raffatellu M, Bode L, Zengler K, Wang M, Siegel D, Knight R, Dorrestein PC. PMID: 39554097; PMCID: PMC11565975.
  14. Correction: Gene expression and chromatin conformation of microglia in virally suppressed people with HIV. Life Sci Alliance. 2025 Jan; 8(1). Schlachetzki JC, Gianella S, Ouyang Z, Lana AJ, Yang X, O’Brien S, Challacombe JF, Gaskill PJ, Jordan-Sciutto KL, Chaillon A, Moore D, Achim CL, Ellis RJ, Smith DM, Glass CK. PMID: 39467638; PMCID: PMC11519389.
  15. Empirically establishing drug exposure records directly from untargeted metabolomics data. bioRxiv. 2024 Oct 26. Zhao HN, Kvitne KE, Brungs C, Mohan S, Charron-Lamoureux V, Bittremieux W, Tang R, Schmid R, Lamichhane S, El Abiead Y, Andalibi MS, Mannochio-Russo H, Ambre M, Avalon NE, Bryant M, Caraballo-Rodríguez AM, Maya MC, Chin L, Ellis RJ, Franklin D, Girod S, Gomes PWP, Hansen L, Heaton R, Iudicello JE, Jarmusch AK, Khatib L, Letendre S, Magyari S, McDonald D, Mohanty I, Cumsille A, Moore DJ, Rajkumar P, Ross DH, Sapre H, Shahneh MRZ, Thomas SP, Tribelhorn C, Tubb HM, Walker C, Wang CX, Xing S, Zemlin J, Zuffa S, Wishart DS, Kaddurah-Daouk R, Wang M, Raffatellu M, Zengler K, Pluskal T, Xu L, Knight R, Tsunoda SM, Dorrestein PC. PMID: 39416075; PMCID: PMC11482764.
  16. A Confirmatory Factor Analysis of the NIH Emotions Toolbox Among People Living with HIV and Who May Use Methamphetamine. AIDS Behav. 2025 Jan; 29(1):55-63. Bender AA, Moore DJ, Perkins MM, Hunt R, Haardörfer R. PMID: 39307896; PMCID: PMC11747901.
  17. Clinical correlates of medication adherence in individuals with bipolar disorder and comorbid hypertension. Int J Psychiatry Med. 2025 Mar; 60(2):203-220. Levin JB, Moore DJ, Briggs F, Rahman M, Montoya J, Depp C, Einstadter D, Stange KC, Weise C, Maniglia T, Barigye R, Howard Griggs G, Adeniyi C, Yala J, Sajatovic M. PMID: 39276142.
  18. Comparing the Efficacy and Efficiency of Human and Generative AI: Qualitative Thematic Analyses. JMIR AI. 2024 Aug 02; 3:e54482. Prescott MR, Yeager S, Ham L, Rivera Saldana CD, Serrano V, Narez J, Paltin D, Delgado J, Moore DJ, Montoya J. PMID: 39094113; PMCID: PMC11329846.
  19. Biopsychosocial phenotypes in people with HIV in the CHARTER cohort. Brain Commun. 2024; 6(4):fcae224. Tang B, Ellis RJ, Vaida F, Umlauf A, Franklin DR, Dastgheyb R, Rubin LH, Riggs PK, Iudicello JE, Clifford DB, Moore DJ, Heaton RK, Letendre SL. PMID: 39077377; PMCID: PMC11285184.
  20. Gene expression and chromatin conformation of microglia in virally suppressed people with HIV. Life Sci Alliance. 2024 Oct; 7(10). Schlachetzki JC, Gianella S, Ouyang Z, Lana AJ, Yang X, O’Brien S, Challacombe JF, Gaskill PJ, Jordan-Sciutto KL, Chaillon A, Moore D, Achim CL, Ellis RJ, Smith DM, Glass CK. PMID: 39060113; PMCID: PMC11282357.
Presentations
  1. [A]
  2. [B]
  3. [C]
Service
  1. [A]
  2. [B]
  3. [C]
Grants
  1. Disentangling Alzheimer’s disease and HIV-Associated Neurocognitive Disorder: Identifying unique neuropsychological profiles with distinct biomarker and neuropathological signatures
    NIH RF1AG061070
    Sep 30, 2018 – Mar 31, 2023
    Role: Principal Investigator
  2. California NeuroAIDS Tissue Networ
    NIH U24MH100928
    May 1, 2013 – Feb 28, 2023
    Role: Principal Investigator
  3. Multi-Dimensional Successful Aging Among HIV-Infected Adults
    NIH R01MH099987
    Jan 1, 2013 – Oct 31, 2019
    Role: Principal Investigator
  4. A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
    NIH R01MH096648
    Sep 6, 2012 – May 31, 2018
    Role: Principal Investigator
  5. Personalized Text Messages to Improve ART Adherence in HIV+ Methamphetamine Users
    NIH R34DA031058
    Apr 15, 2011 – Sep 30, 2014
    Role: Principal Investigator
Clinical Trials
  1. Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals
    Start Date: Jun 2017
    Completion Date: Dec 2020
    Recruitment Status: Completed
    Condition(s): Treatment Adherence,HIV/AIDS,PrEP,Transgender Health
  2. Care4Today v2.0 Application for Improving Adherence to HIV Medications
    Start Date: Oct 2013
    Completion Date: Oct 2014
    Recruitment Status: Completed
    Condition(s): HIV/AIDS
  3. CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM
    Start Date: Dec 2012
    Completion Date: Jun 2014
    Recruitment Status: Completed
    Condition(s): Treatment Adherence,HIV/AIDS,PrEP
  4. Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users
    Start Date: Apr 2011
    Completion Date: Jul 2018
    Recruitment Status: Completed
    Condition(s): HIV/AIDS,Methamphetamines
  5. Texting to Improve Adherence in HIV+ With Bipolar Disorder
    Start Date: Apr 2010
    Completion Date: Mar 2012
    Recruitment Status: Completed
    Condition(s): HIV/AIDS,Bipolar Disorde
Awards & Honors
  1. [A]
  2. [B]
  3. [C]
Patents & Copyrights
  1. [A]
  2. [B]
  3. [C]
Media
  1. [A]
  2. [B]
  3. [C]
Fun Facts
  1. [A]
  2. [B]
  3. [C]